Avni Argun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Avni Argun has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Muhit Rana
Giner, Inc, 89 Rumford Avenue, Newton, MA 02466, USA
4 shared publications - Kenneth Stephen Burch
Boston College
3 shared publications Muhit Rana
Giner Inc, 89 Rumford Ave, Newton, MA 02466 USA
3 shared publications- Narendra Kumar
Boston College
3 shared publications - Sinem Beyhan
Veterans Affairs San Diego Healthcare System, San Diego, USA
3 shared publications Tugba Yilmaz
Giner Inc, 89 Rumford Ave, Newton, MA 02466 USA
3 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Highly sensitive HPLC-MS/MS quantitation of opioids and morphine glucuronides in wastewater using a mid-range triple quadrupole platform
Wastewater-based epidemiology (WBE) is an emerging tool for monitoring community-level opioid consumption, but widespread implementation remains limited by the need for ultra-trace detection in complex wastewater matrices. Many existing methods capable of parts-per-trillion (ppt) quantitation rely on high-end mass spectrometry platforms that are costly and technically demanding. Consequently, there remains a critical need for sensitive and scalable workflows that can be implemented using widely available LC-MS/MS instrumentation. Here, we present a highly sensitive and accessible HPLC-MS/MS method for opioid analysis using a SCIEX Triple Quad 3500, a mid-range triple quadrupole instrument. The method targets opioids and opioid metabolites relevant to WBE: morphine, morphine-3-glucuronide (M3G), morphine-6-glucuronide (M6G), norfentanyl, noroxycodone, methadone, and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP). A key methodological innovation of this workflow is the integration of aqueous reconstitution with large-volume injection following SPE enrichment, enabling ppt-level quantitation on a mid-range triple quadrupole platform. Reconstitution in 100% water improved chromatographic peak shape and signal intensity for polar glucuronide metabolites while allowing a 10-fold increase in injection volume without compromising chromatographic performance. Scheduled multiple reaction monitoring (MRM) further enhanced selectivity and sensitivity for structurally similar analytes, such as M3G and M6G. The method was validated using wastewater samples from the Greater Albany, NY region, demonstrating robust performance in complex matrices. The results establish a scalable framework for ppt-level opioid surveillance using widely accessible LC-MS/MS instrumentation. Importantly, the method enables ppt-level quantitation of opioid glucuronides on a mid-range triple quadrupole platform without requiring high-resolution or premium-tier instrumentation, improving the accessibility of wastewater-based epidemiology workflows.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHighly sensitive HPLC-MS/MS quantitation of opioids and morphine glucuronides in wastewater using a mid-range triple quadrupole platform
Wastewater-based epidemiology (WBE) is an emerging tool for monitoring community-level opioid consumption, but widespread implementation remains limited by the need for ultra-trace detection in complex wastewater matrices. Many existing methods capable of parts-per-trillion (ppt) quantitation rely on high-end mass spectrometry platforms that are costly and technically demanding. Consequently, there remains a critical need for sensitive and scalable workflows that can be implemented using widely available LC-MS/MS instrumentation. Here, we present a highly sensitive and accessible HPLC-MS/MS method for opioid analysis using a SCIEX Triple Quad 3500, a mid-range triple quadrupole instrument. The method targets opioids and opioid metabolites relevant to WBE: morphine, morphine-3-glucuronide (M3G), morphine-6-glucuronide (M6G), norfentanyl, noroxycodone, methadone, and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP). A key methodological innovation of this workflow is the integration of aqueous reconstitution with large-volume injection following SPE enrichment, enabling ppt-level quantitation on a mid-range triple quadrupole platform. Reconstitution in 100% water improved chromatographic peak shape and signal intensity for polar glucuronide metabolites while allowing a 10-fold increase in injection volume without compromising chromatographic performance. Scheduled multiple reaction monitoring (MRM) further enhanced selectivity and sensitivity for structurally similar analytes, such as M3G and M6G. The method was validated using wastewater samples from the Greater Albany, NY region, demonstrating robust performance in complex matrices. The results establish a scalable framework for ppt-level opioid surveillance using widely accessible LC-MS/MS instrumentation. Importantly, the method enables ppt-level quantitation of opioid glucuronides on a mid-range triple quadrupole platform without requiring high-resolution or premium-tier instrumentation, improving the accessibility of wastewater-based epidemiology workflows.
- Open Access
An Ultrasensitive and Novel Gene Sensor to Monitor Gut Microbiome
Infections caused by multi-drug-resistant organisms (MDROs) pose a significant public health threat, responsible for over 2 million hospitalizations and 23,000 deaths annually in the United States. Microbiome dysbiosis (imbalance) is considered one of the main causes for MDRO colonization and the resulting infections. Rapid detection and intervention of MDRO outbreaks are crucial to alleviating strain on patients and healthcare facilities. Current diagnostic methods for MDRO detection are too slow and costly to provide the rapid MDRO detection necessary for patient care facilities. Here we present a rapid, accurate and cost-effective electrochemical sensor capable of MDRO detection down to ∼10 4 colony forming units (CFU)/g in mice and human stool samples. Our novel sensor utilizes probe-modified S creen- P rinted E lectrodes (SPEs) capable of hybridizing target gene sequences associated with MDROs. The resulting probe/target complex generates a unique and highly sensitive signal detectable down to 10 atto molar or 10 CFU/mL of target TEM-1 gene. The use of these pre-functionalized SPEs reduces individual sample analysis time to less than an hour. Several target sequences from two chromosomal target genes (AmpC and AcrB found in E. coli ) have been identified and successfully detected in clinical stool samples with results comparable to the standard quantitative PCR method. Additional target genes associated with antibiotic resistance ( TEM-1, VanA, KPC and SHV ) have also been successfully detected in vitro and are ready for clinical evaluation. Future development includes multiplexing the sensor to simultaneously detect up to three MDROs target genes, including β-lactamases that hydrolyze β-lactams, the most commonly used antibiotics in clinical settings. This novel sensor platform will be a rapid, economical, point-of-care device with little requirement of reagent handling or technical training.
Open AccessAn Ultrasensitive and Novel Gene Sensor to Monitor Gut Microbiome
Infections caused by multi-drug-resistant organisms (MDROs) pose a significant public health threat, responsible for over 2 million hospitalizations and 23,000 deaths annually in the United States. Microbiome dysbiosis (imbalance) is considered one of the main causes for MDRO colonization and the resulting infections. Rapid detection and intervention of MDRO outbreaks are crucial to alleviating strain on patients and healthcare facilities. Current diagnostic methods for MDRO detection are too slow and costly to provide the rapid MDRO detection necessary for patient care facilities. Here we present a rapid, accurate and cost-effective electrochemical sensor capable of MDRO detection down to ∼10 4 colony forming units (CFU)/g in mice and human stool samples. Our novel sensor utilizes probe-modified S creen- P rinted E lectrodes (SPEs) capable of hybridizing target gene sequences associated with MDROs. The resulting probe/target complex generates a unique and highly sensitive signal detectable down to 10 atto molar or 10 CFU/mL of target TEM-1 gene. The use of these pre-functionalized SPEs reduces individual sample analysis time to less than an hour. Several target sequences from two chromosomal target genes (AmpC and AcrB found in E. coli ) have been identified and successfully detected in clinical stool samples with results comparable to the standard quantitative PCR method. Additional target genes associated with antibiotic resistance ( TEM-1, VanA, KPC and SHV ) have also been successfully detected in vitro and are ready for clinical evaluation. Future development includes multiplexing the sensor to simultaneously detect up to three MDROs target genes, including β-lactamases that hydrolyze β-lactams, the most commonly used antibiotics in clinical settings. This novel sensor platform will be a rapid, economical, point-of-care device with little requirement of reagent handling or technical training.
- Open Access
- 2 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4832
Highly Specific Detection of Oxytocin in Saliva
Oxytocin is a peptide neurophysin hormone made up of nine amino acids and is used in induction of one in four births worldwide (more than 13 percent in the United States). Herein, we have developed an antibody alternative aptamer-based electrochemical assay for real-time and point-of-care detection of oxytocin in non-invasive saliva samples. This assay approach is rapid, highly sensitive, specific, and cost-effective. Our aptamer-based electrochemical assay can detect as little as 1 pg/mL of oxytocin in less than 2 min in commercially available pooled saliva samples. Additionally, we did not observe any false positive or false negative signals. This electrochemical assay has the potential to be utilized as a point-of-care monitor for rapid and real-time oxytocin detection in various biological samples such as saliva, blood, and hair extracts.
- 2 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4832
Open AccessHighly Specific Detection of Oxytocin in Saliva
Oxytocin is a peptide neurophysin hormone made up of nine amino acids and is used in induction of one in four births worldwide (more than 13 percent in the United States). Herein, we have developed an antibody alternative aptamer-based electrochemical assay for real-time and point-of-care detection of oxytocin in non-invasive saliva samples. This assay approach is rapid, highly sensitive, specific, and cost-effective. Our aptamer-based electrochemical assay can detect as little as 1 pg/mL of oxytocin in less than 2 min in commercially available pooled saliva samples. Additionally, we did not observe any false positive or false negative signals. This electrochemical assay has the potential to be utilized as a point-of-care monitor for rapid and real-time oxytocin detection in various biological samples such as saliva, blood, and hair extracts.
- 2 December 2022
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 222, 114986
A novel biosensor for ultrasensitive detection of fungal genes
- 2 December 2022
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 222, 114986
A novel biosensor for ultrasensitive detection of fungal genes
- 24 February 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 16 (3) , 3704-3714
Rapid, Multianalyte Detection of Opioid Metabolites in Wastewater
By monitoring opioid metabolites, wastewater-based epidemiology (WBE) could be an excellent tool for real-time information on the consumption of illicit drugs. A key limitation of WBE is the reliance on costly laboratory-based techniques that require substantial infrastructure and trained personnel, resulting in long turnaround times. Here, we present an aptamer-based graphene field effect transistor (AptG-FET) platform for simultaneous detection of three different opioid metabolites. This platform provides a reliable, rapid, and inexpensive method for quantitative analysis of opioid metabolites in wastewater. The platform delivers a limit of detection 2–3 orders of magnitude lower than previous reports, but in line with the concentration range (pg/mL to ng/mL) of these opioid metabolites present in real samples. To enable multianalyte detection, we developed a facile, reproducible, and high-yield fabrication process producing 20 G-FETs with integrated side gate platinum (Pt) electrodes on a single chip. Our devices achieved the selective multianalyte detection of three different metabolites: noroxycodone (NX), 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and norfentanyl (NF) in wastewater diluted 20× in buffer.
- 24 February 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 16 (3) , 3704-3714
Rapid, Multianalyte Detection of Opioid Metabolites in Wastewater
By monitoring opioid metabolites, wastewater-based epidemiology (WBE) could be an excellent tool for real-time information on the consumption of illicit drugs. A key limitation of WBE is the reliance on costly laboratory-based techniques that require substantial infrastructure and trained personnel, resulting in long turnaround times. Here, we present an aptamer-based graphene field effect transistor (AptG-FET) platform for simultaneous detection of three different opioid metabolites. This platform provides a reliable, rapid, and inexpensive method for quantitative analysis of opioid metabolites in wastewater. The platform delivers a limit of detection 2–3 orders of magnitude lower than previous reports, but in line with the concentration range (pg/mL to ng/mL) of these opioid metabolites present in real samples. To enable multianalyte detection, we developed a facile, reproducible, and high-yield fabrication process producing 20 G-FETs with integrated side gate platinum (Pt) electrodes on a single chip. Our devices achieved the selective multianalyte detection of three different metabolites: noroxycodone (NX), 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and norfentanyl (NF) in wastewater diluted 20× in buffer.
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
A Novel Biosensor for Ultrasensitive Detection of Fungal Genes
Fungal infections are a rapidly increasing public health problem due to their high morbidity and mortality rates, especially in populations with compromised immune systems. Rapid and accurate diagnosis of these diseases is, therefore, necessary to improve the prognosis of afflicted patients. Unfortunately, current clinical chemistry practice relies on lengthy culturing methods that are insufficient to meet the fast turnaround requirements. Here we present a cost-effective and robust nucleic acid sensor that can identify the presence of histoplasmosis causing fungal genes, in whole blood or Bronchoalveolar lavage (BAL) samples, far earlier than current methods. Our novel assay involves the hybridization of target gene sequences with immobilized nucleic acid probes, allowing direct, label-free detection of Hcp100, CBP1, and M antigen genes through electrochemical analysis. The resultant current is attributed to the presence of fungal targets in the sample solution. The assay provides ultra-sensitive detection of DNA molecules with a limit of detection (LOD) values down to 100 aM, sufficient to meet the clinical diagnostic need. In addition, the turnaround time for the sample to result is less than 90 minutes compared to the current clinical procedure’s turnaround time of 3-4 weeks.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Novel Biosensor for Ultrasensitive Detection of Fungal Genes
Fungal infections are a rapidly increasing public health problem due to their high morbidity and mortality rates, especially in populations with compromised immune systems. Rapid and accurate diagnosis of these diseases is, therefore, necessary to improve the prognosis of afflicted patients. Unfortunately, current clinical chemistry practice relies on lengthy culturing methods that are insufficient to meet the fast turnaround requirements. Here we present a cost-effective and robust nucleic acid sensor that can identify the presence of histoplasmosis causing fungal genes, in whole blood or Bronchoalveolar lavage (BAL) samples, far earlier than current methods. Our novel assay involves the hybridization of target gene sequences with immobilized nucleic acid probes, allowing direct, label-free detection of Hcp100, CBP1, and M antigen genes through electrochemical analysis. The resultant current is attributed to the presence of fungal targets in the sample solution. The assay provides ultra-sensitive detection of DNA molecules with a limit of detection (LOD) values down to 100 aM, sufficient to meet the clinical diagnostic need. In addition, the turnaround time for the sample to result is less than 90 minutes compared to the current clinical procedure’s turnaround time of 3-4 weeks.
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
A Novel Electrochemical Assay to Detect Fungal Genes
Rapid and accurate diagnosis of fungal diseases is an urgent medical need. The public health impact of fungal infections is on the increase due to high morbidity and mortality, especially in immune-compromised patients. Unfortunately, current medical diagnostics outside of lengthy culturing methods are insufficient to meet clinical requirements. The overall goal of this study is to develop a cost-effective and robust nucleic acid sensor that can rapidly and accurately identify the presence of Histoplasma-specific fungal genes to yield an early and definitive diagnosis of histoplasmosis. Our assay involves the hybridization of target gene sequences with immobilized nucleic acid probes, allowing direct, label-free detection of target organisms using an electrochemical output signal. The resultant current is attributed to the presence of fungal target genes in the sample solution, specifically Hcp100 , CBP1 , or M antigen. The assay provides ultra-sensitive detection of DNA molecules with a limit of detection (LOD) values down to 100 attomolar (aM), sufficient to meet the clinical diagnostic need. In addition, the turnaround time for the sample to result is relatively fast (≤90 mins). We have successfully developed this electrochemical assay capable of rapid, highly specific, and sensitive detection of Histoplasma specific genes in whole blood and Bronchoalveolar lavage (BAL) samples.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Novel Electrochemical Assay to Detect Fungal Genes
Rapid and accurate diagnosis of fungal diseases is an urgent medical need. The public health impact of fungal infections is on the increase due to high morbidity and mortality, especially in immune-compromised patients. Unfortunately, current medical diagnostics outside of lengthy culturing methods are insufficient to meet clinical requirements. The overall goal of this study is to develop a cost-effective and robust nucleic acid sensor that can rapidly and accurately identify the presence of Histoplasma-specific fungal genes to yield an early and definitive diagnosis of histoplasmosis. Our assay involves the hybridization of target gene sequences with immobilized nucleic acid probes, allowing direct, label-free detection of target organisms using an electrochemical output signal. The resultant current is attributed to the presence of fungal target genes in the sample solution, specifically Hcp100 , CBP1 , or M antigen. The assay provides ultra-sensitive detection of DNA molecules with a limit of detection (LOD) values down to 100 attomolar (aM), sufficient to meet the clinical diagnostic need. In addition, the turnaround time for the sample to result is relatively fast (≤90 mins). We have successfully developed this electrochemical assay capable of rapid, highly specific, and sensitive detection of Histoplasma specific genes in whole blood and Bronchoalveolar lavage (BAL) samples.
- Open Access
Rapid, multianalyte detection of opioid metabolites in wastewater
By monitoring opioid metabolites, wastewater-based epidemiology (WBE) could be an excellent tool for real-time information on consumption of illicit drugs. A key limitation of WBE is the reliance on costly laboratory-based techniques that require substantial infrastructure and trained personnel, resulting in long turnaround times. Here, we present an aptamer-based graphene field effect transistor (AptG-FET) platform for simultaneous detection of three different opioid metabolites. This platform provides a reliable, rapid, and inexpensive method for quantitative analysis of opioid metabolites in wastewater (WW). The platform delivers a limit of detection (LOD) 2-3 orders of magnitude lower than previous reports, but in line with the concentrations range (pg/ml to ng/ml) of these opioid metabolites present in real samples. To enable multianalyte detection we developed a facile, reproducible, and high yield fabrication process producing twenty G-FETs with integrated side gate platinum (Pt) electrodes on a single chip. Our devices achieved the simultaneous and selective multianalyte detection of three different metabolites: Noroxycodone (NX), 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and Norfentanyl (NF) in wastewater.
Open AccessRapid, multianalyte detection of opioid metabolites in wastewater
By monitoring opioid metabolites, wastewater-based epidemiology (WBE) could be an excellent tool for real-time information on consumption of illicit drugs. A key limitation of WBE is the reliance on costly laboratory-based techniques that require substantial infrastructure and trained personnel, resulting in long turnaround times. Here, we present an aptamer-based graphene field effect transistor (AptG-FET) platform for simultaneous detection of three different opioid metabolites. This platform provides a reliable, rapid, and inexpensive method for quantitative analysis of opioid metabolites in wastewater (WW). The platform delivers a limit of detection (LOD) 2-3 orders of magnitude lower than previous reports, but in line with the concentrations range (pg/ml to ng/ml) of these opioid metabolites present in real samples. To enable multianalyte detection we developed a facile, reproducible, and high yield fabrication process producing twenty G-FETs with integrated side gate platinum (Pt) electrodes on a single chip. Our devices achieved the simultaneous and selective multianalyte detection of three different metabolites: Noroxycodone (NX), 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and Norfentanyl (NF) in wastewater.
- Open Access
Detection of a multi-disease biomarker in Saliva with Graphene Field Effect Transistors
Human carbonic anhydrase 1 (CA1) has been suggested as a biomarker for identification of several diseases including cancers, pancreatitis, diabetes, and Sjogren’s syndrome. However, the lack of a rapid, cheap, accurate, and easy-to-use quantification technique has prevented widespread utilization of CA1 for practical clinical applications. To this end, we present a label-free electronic biosensor for detection of CA1 utilizing highly sensitive graphene field effect transistors (G-FETs) as a transducer and specific RNA aptamers as a probe. The binding of CA1 with aptamers resulted in a positive shift in Dirac voltage V D of the G-FETs, the magnitude of which depended on target concentration. These aptameric G-FET biosensors showed the binding affinity ( K D ) of ∼ 2.3 ng/ml (70 pM), which is four orders lower than that reported using a gel shift assay. This lower value of K D enabled us to achieve a detection range (10 pg/ml - 100 ng/ml) which is well in line with the clinically relevant range. These highly sensitive devices allowed us to further prove their clinical relevance by successfully detecting the presence of CA1 in human saliva samples. Utilization of this label-free biosensor could facilitate the early stage identification of various diseases associated with changes in concentration of CAs.
Open AccessDetection of a multi-disease biomarker in Saliva with Graphene Field Effect Transistors
Human carbonic anhydrase 1 (CA1) has been suggested as a biomarker for identification of several diseases including cancers, pancreatitis, diabetes, and Sjogren’s syndrome. However, the lack of a rapid, cheap, accurate, and easy-to-use quantification technique has prevented widespread utilization of CA1 for practical clinical applications. To this end, we present a label-free electronic biosensor for detection of CA1 utilizing highly sensitive graphene field effect transistors (G-FETs) as a transducer and specific RNA aptamers as a probe. The binding of CA1 with aptamers resulted in a positive shift in Dirac voltage V D of the G-FETs, the magnitude of which depended on target concentration. These aptameric G-FET biosensors showed the binding affinity ( K D ) of ∼ 2.3 ng/ml (70 pM), which is four orders lower than that reported using a gel shift assay. This lower value of K D enabled us to achieve a detection range (10 pg/ml - 100 ng/ml) which is well in line with the clinically relevant range. These highly sensitive devices allowed us to further prove their clinical relevance by successfully detecting the presence of CA1 in human saliva samples. Utilization of this label-free biosensor could facilitate the early stage identification of various diseases associated with changes in concentration of CAs.